Access hundreds of peer-reviewed cognitive research papers published by leading neuroscientists using Cogstate technology.



Cogstate tasks, including the Cogstate Brief Battery™, have been included in published studies across various indications.

Use the fields on the left to search specific areas of interest, including sensitivity in Alzheimer’s disease, Depression, Concussion/Athletes, AIDS/HIV, Schizophrenia, ADHD and Alcohol; as well as properties, demographic features and cultural validity.

Latest Publications

Effect of Chlorogenic Acid Intake on Cognitive Function in the Elderly: A Pilot Study.

Authors: Kato M, Katsuragi Y, Kozuma K, Ochiai R, Sato H

Journal: Evidence-based complementary and alternative medicine

DOI: 10.1155/2018/8608497

Year Published: 2018

Objective: To evaluate the effect of chlorogenic acids (CGAs) intake on cognitive function. Methods: In this pilot study, the Cogstate and CNS Vital Signs test batteries were used to evaluate cognitive function in 8 healthy elderly men and women complaining of subjective memory loss after a 6-month intake of a test beverage containing 330 mg of […]

Impaired visual, working, and verbal memory in first-episode, drug-naive patients with major depressive disorder in a Chinese population.

Authors: Chen C, Gao CG, Hashimoto K, Jiang WH, Li Y, Ma XC, Wang W, Wu J

Journal: Public Library of Science One

Volume & Issue: 13 & 4

DOI: 10.1371/journal.pone.0196023

Year Published: 2018

Cognitive impairment has been observed in patients with major depressive disorder (MDD). However, it remains unclear whether the deficits in specific cognitive domains are present in first-episode, drug-naïve patients or medicated patients. In the present study, using the CogState battery (CSB) Chinese language version, we evaluated the visual, working, and verbal memory in first-episode drug-naive […]

Baseline Amnestic Severity Predicts Progression From Amnestic Mild Cognitive Impairment to Alzheimer Disease Dementia at 3 Years.

Authors: Ames D, Bradfield NI, Burnham S, Darby D, Ellis KA, Lautenschlager NT, Martins RN, Maruff P, Masters CL, Rainey-Smith SR, Robertson J, Rowe C, Savage G, Woodward M

Journal: Alzheimer Disease and Associated Disorders

DOI: 10.1097/WAD.0000000000000252

Year Published: 2018

BACKGROUND: Given the long preclinical disease course of Alzheimer disease (AD) pathology, novel treatments may be more efficacious if administered before the emergence of dementia. Thus, accurate prediction of who will develop AD dementia is of key importance in selecting individuals for trials of treatment and may become crucial for future selection of patients for […]